NDC 61958-2005 – Descovy

Emtricitabine 120 mg/1; Tenofovir Alafenamide Fumarate 15 mg/1 · Tablet · Oral

Human Prescription Drug

Product NDC61958-2005

Product details

Brand name
Descovy
Generic name
emtricitabine and tenofovir alafenamide
Labeler
Gilead Sciences, Inc.
Dosage form
Tablet
Route
Oral
Marketing category
NDA · NDA208215
Marketed since
January 7, 2022
Listing expires
December 31, 2027
Pharmacologic class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Descovy →

Package NDC codes (1)

Package NDCDescriptionSince
61958-2005-130 TABLET in 1 BOTTLE, PLASTIC (61958-2005-1)Jan 7, 2022

Other Descovy products